摘要
89SrCl2、153Sm-EDTMP、188Re-HEDP以及与它们相关的联合治疗方法对多发性骨转移瘤患者的姑息止痛效果为70%-90%以上,其疗效与病理类型密切相关;153Sm-EDTMP的骨髓抑制作用较89SrCl2严重,临床可首选188Re-HEDP或89SrCl2。
The relief rate of bone pain in metastases was between 70% and more than 90% treated by ^89SrCl2, ^153Sm-EDTMP, ^188Re- HEDP,and combined with radio-pharmaceuticals. The treatment effect of them was mostly correlated with tumor＇s pathological type. The marrow depress effect of ^153Sm-EDTMP was higher than that of ^89SrCl2. So,^188Re-HEDP or ^89SrCl2 can be chosen primarily in u-eating bone metastasis.
出处
《川北医学院学报》
CAS
2007年第1期60-63,共4页
Journal of North Sichuan Medical College
